Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
143.3
Price to sales ratio
6.14
Dividends per share
1.92
Dividend yield %
2.48

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
93
WELL
Welltower Inc. Common Stock
237.96 USD-0.66%-0.63%+1.48%+41.99%171.51 B USD
725
DOC
Healthpeak Properties, Inc. Common Stock
20.96 USD-1.27%-2.83%-4.07%+17.29%14.45 B USD
745
OHI
Omega Healthcare Investors, Inc. Common Stock
46.00 USD-0.63%-1.60%-7.82%+13.85%13.94 B USD
819
AHR
American Healthcare REIT, Inc. Common Stock
55.55 USD-1.65%-1.09%+0.05%+31.92%12.11 B USD

Frequently asked questions about Ventas, Inc.

What is the Ventas, Inc. stock price today?

The current price of Ventas, Inc. (VTR) is 91.79. Over the past 24 hours, the stock has changed by -1.18%. Follow the VTR chart for real-time price dynamics.

What is the stock ticker of Ventas, Inc.?

Ventas, Inc. trades under the ticker VTR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Ventas, Inc. stock going up?

VTR has changed by -2.24% over the last week, -1.35% over the last month, and +30.64% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Ventas, Inc.?

Ventas, Inc. currently has a market capitalization of 47.08 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Ventas, Inc. release financial reports?

Yes. You can track Ventas, Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Ventas, Inc. earnings last quarter?

Last quarter, Ventas, Inc. reported earnings of 0.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Ventas, Inc. revenue for the last quarter?

Ventas, Inc. reported quarterly revenue of 1.73 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Ventas, Inc. net income for the last quarter?

Ventas, Inc. reported net income of 72.22 M for the last quarter. The previous quarter showed 59.05 M, which means net income changed by +22.31%.

Does Ventas, Inc. pay dividends?

Ventas, Inc. paid a dividend per share of 0.52. The current dividend yield is 3.87%. Dividend data can help income-focused investors evaluate the stock.

Is Ventas, Inc. a good dividend stock?

Ventas, Inc. currently has a dividend yield of 3.87%. Previously, the dividend yield was 4.16%, compared with 2.48% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.

How many employees does Ventas, Inc. have?

As of the latest available data, Ventas, Inc. has 542 employees. Workforce size can provide additional context about the company's scale and operations.

What is Ventas, Inc. EBITDA?

Ventas, Inc. EBITDA is 62.06 M, and its EBITDA margin is 3.59%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Ventas, Inc. stock?

You can buy Ventas, Inc. (VTR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Ventas, Inc. stock?

Investing in Ventas, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VTR chart and related analysis on metatrader.com as part of your research.

Ventas, Inc. Common Stock

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom. As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion. As of 2019, it is a Fortune 1000 corporation.

News